Glenmede Trust Co. NA reduced its position in Morgan Stanley (NYSE:MS – Free Report) by 1.1% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 150,971 shares of the financial services provider’s stock after selling 1,693 shares during the period. Glenmede Trust Co. NA’s holdings in Morgan Stanley were worth $15,737,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of the business. Principal Financial Group Inc. grew its holdings in shares of Morgan Stanley by 0.8% during the third quarter. Principal Financial Group Inc. now owns 4,711,805 shares of the financial services provider’s stock valued at $491,159,000 after buying an additional 36,120 shares during the last quarter. Resonant Capital Advisors LLC boosted its stake in Morgan Stanley by 17.8% during the 2nd quarter. Resonant Capital Advisors LLC now owns 5,768 shares of the financial services provider’s stock valued at $561,000 after purchasing an additional 871 shares during the last quarter. Cetera Investment Advisers increased its holdings in Morgan Stanley by 115.0% during the 1st quarter. Cetera Investment Advisers now owns 223,668 shares of the financial services provider’s stock worth $20,305,000 after purchasing an additional 119,633 shares in the last quarter. Catalytic Wealth RIA LLC purchased a new stake in shares of Morgan Stanley in the third quarter worth approximately $579,000. Finally, Natixis Advisors LLC lifted its holdings in shares of Morgan Stanley by 1.4% in the third quarter. Natixis Advisors LLC now owns 1,152,937 shares of the financial services provider’s stock valued at $120,182,000 after purchasing an additional 16,350 shares in the last quarter. Institutional investors and hedge funds own 84.19% of the company’s stock.
Analysts Set New Price Targets
A number of equities research analysts recently commented on the company. Royal Bank of Canada increased their price target on Morgan Stanley from $108.00 to $122.00 and gave the company a “sector perform” rating in a research report on Thursday, October 17th. Citigroup increased their target price on shares of Morgan Stanley from $105.00 to $135.00 and gave the company a “neutral” rating in a report on Monday. The Goldman Sachs Group boosted their price target on shares of Morgan Stanley from $106.00 to $121.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. Wells Fargo & Company raised shares of Morgan Stanley from an “underweight” rating to an “equal weight” rating and lifted their target price for the stock from $107.00 to $142.00 in a research report on Friday, November 15th. Finally, UBS Group boosted their target price on Morgan Stanley from $102.00 to $112.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 8th. Eleven analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, Morgan Stanley currently has a consensus rating of “Hold” and an average target price of $118.00.
Insider Buying and Selling
In other Morgan Stanley news, Director Stephen J. Luczo sold 60,000 shares of the business’s stock in a transaction on Thursday, October 17th. The shares were sold at an average price of $119.17, for a total transaction of $7,150,200.00. Following the sale, the director now owns 138,363 shares of the company’s stock, valued at $16,488,718.71. The trade was a 30.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.24% of the stock is owned by insiders.
Morgan Stanley Stock Performance
Shares of MS opened at $131.21 on Friday. Morgan Stanley has a 1 year low of $76.33 and a 1 year high of $136.24. The company has a debt-to-equity ratio of 3.14, a current ratio of 0.80 and a quick ratio of 0.80. The stock’s fifty day moving average price is $118.71 and its two-hundred day moving average price is $106.14. The firm has a market cap of $211.38 billion, a PE ratio of 19.97, a PEG ratio of 1.24 and a beta of 1.34.
Morgan Stanley (NYSE:MS – Get Free Report) last announced its quarterly earnings data on Wednesday, October 16th. The financial services provider reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.31. The business had revenue of $15.38 billion for the quarter, compared to analysts’ expectations of $14.27 billion. Morgan Stanley had a return on equity of 12.58% and a net margin of 10.64%. On average, equities research analysts forecast that Morgan Stanley will post 7.32 EPS for the current year.
Morgan Stanley Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Thursday, October 31st were paid a dividend of $0.925 per share. This represents a $3.70 dividend on an annualized basis and a dividend yield of 2.82%. The ex-dividend date was Thursday, October 31st. Morgan Stanley’s payout ratio is currently 56.32%.
About Morgan Stanley
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Further Reading
- Five stocks we like better than Morgan Stanley
- What is a Death Cross in Stocks?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Stock Market Upgrades: What Are They?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.